The IBN SINA Pharmaceutical Industry PLC reported earnings results for the third quarter and nine months ended March 31, 2024. For the third quarter, the company reported sales was BDT 2,554.04 million compared to BDT 2,022.84 million a year ago. Net income was BDT 134.55 million compared to BDT 93.25 million a year ago. Basic earnings per share from continuing operations was BDT 4.31 compared to BDT 2.99 a year ago.
For the nine months, sales was BDT 8,379.87 million compared to BDT 6,638.95 million a year ago. Net income was BDT 506.67 million compared to BDT 422.29 million a year ago.